Recent Blog Posts

View Post: Melanoma (Skin) Clinical Trial: Cyclophosphamide, Autologous ...
29 Oct 2009
Aldesleukin may stimulate the... Date First Received: October 30, 2009. Last Updated: October 30, 2009. Verified by: National Cancer Institute (NCI), July 2009. Clinical Trial Phase: Phase 1/Phase 2 ...
View Blog: http://clinicaltrialsfeeds.org/clinical-trials/results/7-days/

---

View Post: Everolimus for advanced renal cell cancer after VEGF-inhibitors ...
2 Oct 2009 by bowersc  
Interleukin-2 (aldesleukin) can result in a median duration of response of about 54 months, but it is not always tolerated. Everolimus is in clinical trials for other types of cancer and for transplantation. Study details ...
View Blog: NPCi blog - http://www.npci.org.uk/blog/

---

View Post: aldesleukin (proleukin®)
12 Jun 2007 by Xincon  
this information is about the use of aldesleukin (pronounced al-des-loo-kin) as a treatment for people with cancer. it is mainly used to treat people with a type of kidney cancer known as renal cell carcinoma, but is sometimes used to ...
View Blog: Online Cancer Information - http://online-cancer-information.blogspot.com/

---

View Post: Orphan drug designation granted to TNFerade for pancreatic cancer ...
4 Nov 2009
GenVec was granted orphan drug designation by the FDA for its drug candidate, TNFerade for the treatment of pancreatic cancer. ... Neoplasms > Biological response modifiers. Aldesleukin 22 million IU/vial; pwd for IV infusion after reconstitution and dilution; contains mannitol; preservative-free. ...
View Blog: Latest articles from MPR - http://www.empr.com/

---

View Post: vaccine therapy and aldesleukin in treating women with metastatic ...
1 Nov 2008
condition: breast cancer interventions: drug: aldesleukin; procedure: flow cytometry; procedure: immunoenzyme technique; procedure: laboratory biomarker analysis; procedure: tumor cell-based vaccine therapy ...
View Blog: clinicaltrials.gov: allergy

---

View Post: Proleukin (Aldesleukin) Drug Information: Uses, Side Effects, Drug ...
11 Sep 2008
USES: Aldesleukin is used to treat advanced forms of kidney or skin cancer (cancer that has spread to other parts of the body). This medication is the same as a substance that your body normally makes (interleukin-2). ...
View Blog: RxList - News and Features - http://www.rxlist.com/script/main/hp.asp

---

View Post: renal cell carcinoma :: proleukin il-2 therapy (aldesleukin)
14 Oct 2008 by mp3mac4  
renal cell carcinoma is a type of kidney cancer in which the cancerous cells are ... the growth of some renal cell carcinomas, including cancers that have spread. ... renal cell carcinoma. renal cell carcinoma, a form of kidney cancer ...
View Blog: seenyournews - http://seenyournews-giy.blogspot.com/

---

View Post: aldesleukin
29 Mar 2009 by oraclewriter  
aldesleukin is a type of man-made protein that is used to treat wide-spread cancer or metastatic cancer of the kidney and of the skin. it is currently under observation as a cure to other diseases such as hiv infection, kaposi's sarcoma ...
View Blog: Expert Content - http://articles.kosmix.com/

---

View Post: Kidney cancer symptoms, Kidney cancer cure, Kidney cancer
27 Aug 2009 by admin  
In metastatic kidney cancer patients, the use of alpha or interleukin-2 (IL-2 or aldesleukin) is medically advised. This is innately produced by the body in small quantities on encountering any infection. Cancer fighting drugs are ...
View Blog: Simple Health Guide - http://www.simplehealthguide.com/

---

View Post: aldesleukin
2 Mar 2008 by Fiza  
other warnings/precautions: experienced physician: [us boxed warning]: should be administered under the supervision of an experienced cancer chemotherapy physician in a facility with cardiopulmonary or intensive specialists and ...
View Blog: Drug Information Directory - http://druginformation-directory.blogspot.com/

---